Terry D. Lindstrom

Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor

Patrick C. May, Robert A. Dean, Stephen L. Lowe et al. · Journal of Neuroscience · 2011 · 365 citations · Full text

Robust Central Reduction, Amyloid-β Peptide, Neurochemical Biomarkers +21

Intra- and interstrain differences in models of “behavioral despair”

Fengju Bai, Xia Li, Michael P. Clay et al. · Pharmacology Biochemistry and Behavior · 2001 · 245 citations

Psychological Co-morbidities, Psychopathology, Affective Neuroscience +4

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Xia Li, Joseph P. Tizzano, Kelly Griffey et al. · Neuropharmacology · 2001 · 223 citations

Molecular Pharmacology, Psychiatry, Medicine +7

The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans

Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 195 citations · Full text

Amyloid β, Neurodegenerative Diseases, Amyloid Lowering +15

Substituted 3-Imidazo[1,2-<i>a</i>]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino- [6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3

Thomas A. Engler, James R. Henry, Sushant Malhotra et al. · Journal of Medicinal Chemistry · 2004 · 100 citations · Full text

Insulin Receptor, Pharmaceutical Chemistry, Insulin Signaling +18